Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Cash from Financing Activities (2016 - 2025)

Skinvisible's Cash from Financing Activities history spans 15 years, with the latest figure at $34780.0 for Q1 2025.

  • On a quarterly basis, Cash from Financing Activities rose 78.36% to $34780.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $34780.0, a 60.7% decrease, with the full-year FY2025 number at $34780.0, down 60.7% from a year prior.
  • Cash from Financing Activities hit $34780.0 in Q1 2025 for Skinvisible, up from $26636.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SKVI hit a ceiling of $36200.0 in Q2 2024 and a floor of -$137000.0 in Q4 2021.
  • Historically, Cash from Financing Activities has averaged -$19632.0 across 4 years, with a median of $5082.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 18400.0% in 2021 and later surged 565.9% in 2024.
  • Tracing SKVI's Cash from Financing Activities over 4 years: stood at -$137000.0 in 2021, then surged by 102.92% to $4000.0 in 2023, then surged by 565.9% to $26636.0 in 2024, then skyrocketed by 30.58% to $34780.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for SKVI at $34780.0 in Q1 2025, $26636.0 in Q4 2024, and $6164.0 in Q3 2024.